IL1B and invasive breast carcinoma: Stromal OSM expression was 5.9-fold higher in invasive breast cancer compared to normal breast samples (Figure 6A), and stromal IL-1β was 5.4-fold higher in invasive breast cancer compared to normal samples (Figure 6B).